Published in Blood on October 01, 1985
Biochemistry of the glycosyl-phosphatidylinositol membrane protein anchors. Biochem J (1987) 3.74
Release of decay-accelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J Exp Med (1986) 3.68
Deficiency of lymphocyte function-associated antigen 3 (LFA-3) in paroxysmal nocturnal hemoglobinuria. Functional correlates and evidence for a phosphatidylinositol membrane anchor. J Exp Med (1987) 1.27
Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med (1988) 1.07
Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J Clin Invest (1991) 0.88
Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins. J Clin Invest (1991) 0.82
Acute myeloblastic leukemia in paroxysmal nocturnal hemoglobinuria. Evidence of evolution from the abnormal paroxysmal nocturnal hemoglobinuria clone. J Clin Invest (1987) 0.78
Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med (1994) 15.82
Pain in sickle cell disease. Rates and risk factors. N Engl J Med (1991) 9.75
CD44--a molecule involved in leukocyte adherence and T-cell activation. Immunol Today (1989) 2.96
The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature (1988) 2.66
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest (1966) 2.58
Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol (1989) 1.93
The cooperative study of sickle cell disease: review of study design and objectives. Am J Pediatr Hematol Oncol (1982) 1.85
Morphologic changes in the membranes of red blood cells undergoing hemolysis. Am J Med (1966) 1.70
An auto-anti-M causing hemolysis in vitro. Transfusion (1991) 1.60
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. 3. The membrane defects caused by complement lysis. J Exp Med (1966) 1.57
Paroxysmal nocturnal haemoglobinuria. Clin Haematol (1985) 1.55
Familial cold urticaria. A generalized reaction involving leukocytosis. Arch Intern Med (1969) 1.53
Large-scale use of red blood cell units containing alloantibodies. Immunohematology (2000) 1.39
Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results. Ann Surg (1987) 1.37
The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood (1996) 1.34
Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1982) 1.32
Acquired DNA mutations associated with in vivo hydroxyurea exposure. Blood (2000) 1.29
Mechanisms of immune lysis of red blood cells in vitro. I. Paroxysmal nocturnal hemoglobinuria cells. J Clin Invest (1973) 1.29
Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest (1998) 1.27
Platelet antibody in autoimmune thrombocytopenia. Br J Haematol (1975) 1.27
Human erythrocyte antigens. Regulation of expression of a novel erythrocyte surface antigen by the inhibitor Lutheran In(Lu) gene. J Clin Invest (1983) 1.26
Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria. J Clin Invest (1974) 1.24
Variations in the red cells in paroxysmal nocturnal haemoglobinuria. Br J Haematol (1973) 1.24
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. J Immunol (1983) 1.24
Comparison of binding characteristics of factors B and H to C3b on normal and paroxysmal nocturnal hemoglobinuria erythrocytes. J Immunol (1983) 1.20
Chlorpropamide-induced immune hemolytic anemia. N Engl J Med (1970) 1.20
Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest (1987) 1.18
Quantitative influence of antibody and complement coating of red cells on monocyte-mediated cell lysis. J Clin Invest (1978) 1.18
Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem (1994) 1.17
Fixation of the first component of complement (C'la) by human antibodies. J Clin Invest (1969) 1.17
Normal polymorphic variations and transcription of the decay accelerating factor gene in paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci U S A (1988) 1.14
Erythrocyte membrane inhibitor of reactive lysis: effects of phosphatidylinositol-specific phospholipase C on the isolated and cell-associated protein. Blood (1990) 1.13
Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood (1993) 1.13
Characterization of the complement sensitivity of paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest (1985) 1.12
Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis. J Clin Invest (1966) 1.11
Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin Invest (1973) 1.10
The lysis of paroxysmal nocturnal haemoglobinuria red cells by serum and cobra factor. Br J Haematol (1972) 1.10
Characterization of the IgG-Fc receptor on human platelets. Blood (1982) 1.09
Immune thrombocytopenia in lymphoproliferative diseases. Blood (1979) 1.08
Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J Immunol (1993) 1.08
The variability of hemolysis in the cold agglutinin syndrome. Blood (1980) 1.08
Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med (1988) 1.07
Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest (1989) 1.07
Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest (1984) 1.07
Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets. J Clin Invest (1977) 1.07
Reaction of cold agglutinins with I antigen solubilized from human red cells. Blood (1970) 1.06
The population of cells in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis: significance and mechanism of increased immune lysis. Br J Haematol (1974) 1.05
Human erythrocyte antigens. III. Characterization of a panel of murine monoclonal antibodies that react with human erythrocyte and erythroid precursor membranes. Vox Sang (1987) 1.04
Further evidence for location of the spherocytosis gene on chromosome 8. Ann Intern Med (1983) 1.04
Two populations of granulocytes in paroxysmal nocturnal hemoglobinuria. Blood (1979) 1.03
Increased efficiency of binding of nascent C3b to the erythrocytes of chronic cold agglutinin disease. J Clin Invest (1984) 1.02
Characterization of the serum In(Lu)-related antigen: identification of a serum protein related to erythrocyte p80. Blood (1989) 1.02
The use of in vitro technics to study drug-induced pancytopenia. N Engl J Med (1979) 1.01
Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Pathol (1994) 1.00
The structure of the urokinase-type plasminogen activator receptor gene. Blood (1994) 0.99
Production of IgM hexamers by normal and autoimmune B cells: implications for the physiologic role of hexameric IgM. J Immunol (1998) 0.99
Mutations within the Piga gene in patients with paroxysmal nocturnal hemoglobinuria. Blood (1994) 0.99
Human erythrocyte antigens: II. The In(Lu) gene regulates expression of an antigen on an 80-kilodalton protein of human erythrocytes. Blood (1984) 0.99
Cardiac metastasis from a transitional cell carcinoma: a case report. Med Oncol (2000) 0.98
Erythrocyte blood group antigens: not so simple after all. Blood (1995) 0.98
Fragment D-dimer levels: an objective marker of vaso-occlusive crisis and other complications of sickle cell disease. Blood (1986) 0.98
The response of human neutrophils to a chemotactic tripeptide (N-formyl-methionyl-leucyl-phenylalanine) studied by microcinematography. Blood (1984) 0.97
Cold-reacting antibodies: differences in the reaction of anti-I antibodies with adult and cord red blood cells. Blood (1970) 0.97
Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood (1994) 0.97
Separation of the acetylcholinesterase-deficient red cells in paroxysmal nocturnal hemoglobinuria. Blood (1986) 0.96
Cold-reacting antibodies: the enhancement of antibody fixation by the first component of complement (C'1a). J Immunol (1968) 0.96
Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Blood (1969) 0.95
Critical factors in basal cell adhesion molecule/lutheran-mediated adhesion to laminin. J Biol Chem (1999) 0.95
Structure-function relationships of the complement regulatory protein, CD59. Blood Cells Mol Dis (1996) 0.94
Paroxysmal nocturnal haemoglobinuria in aplastic anaemia. Clin Haematol (1978) 0.94
Differences in the terminal steps of complement lysis of normal and paroxysmal nocturnal hemoglobinuria red cells. Blood (1978) 0.94
Structure of the CD59-encoding gene: further evidence of a relationship to murine lymphocyte antigen Ly-6 protein. Proc Natl Acad Sci U S A (1992) 0.94
Quantitative immunology of immune hemolytic anemia. I. The fixation of C1 by autoimmune antibody and heterologous anti-IgG antibody. J Clin Invest (1971) 0.94
The spleen as a filter. N Engl J Med (1987) 0.94
Human red cell antigens. IV. The abnormal sialoglycoprotein of Gerbich-negative red cells. Transfusion (1987) 0.94
The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria. Blood (1971) 0.94
Inhibitors of complement derived from the erythrocyte membrane in paroxysmal nocturnal hemoglobinuria. Blood (1980) 0.93
Platelet-bound complement (C3) in immune thrombocytopenia. Blood (1977) 0.93
Molecular defects underlying the Kell null phenotype. J Biol Chem (2001) 0.93
The reactivity of red blood cell membrane glycophorin with "cold-reacting" antibodies. Clin Immunol Immunopathol (1975) 0.91
Complement-dependent immune adherence measured with human granulocytes: changes in the antigenic nature of red cell-bound C3 produced by incubation in human serum. Clin Immunol Immunopathol (1973) 0.91
The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria. Blood (1986) 0.91
Identification of human erythrocyte blood group antigens on the C3b/C4b receptor. J Immunol (1991) 0.90
Prevention and diagnosis of delayed haemolytic transfusion reactions. Vox Sang (2006) 0.90
Expression of cell adhesion molecule CD44 in primary tumors of the liver: an immunohistochemical study. Liver (1997) 0.90
Intravenous immunoglobulin administration in the treatment of severe chronic immune thrombocytopenic purpura. Am J Med (1984) 0.90
Treatment of paroxysmal nocturnal hemoglobinuria. Blood (1982) 0.90
Pseudo-Bernard-Soulier syndrome: thrombocytopenia caused by autoantibody to platelet glycoprotein Ib. Blood (1987) 0.89
Paroxysmal nocturnal hemoglobinuria--present status and future prospects. West J Med (1980) 0.89
Red-cell abnormalities in HEMPAS (hereditary erythroblastic multinuclearity with a positive acidified-serum test). Br J Haematol (1972) 0.89
Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood (1992) 0.88
Distinct restriction of complement- and cell-mediated lysis. J Immunol (1989) 0.88
The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria. Blood (1998) 0.88
Regulation of the activity of platelet-bound C3 convertase of the alternative pathway of complement by platelet factor H. Proc Natl Acad Sci U S A (1987) 0.88
Successful treatment of hepatitis C in sickle-cell disease. Ann Intern Med (2000) 0.88
Structural characteristics of hemolytic antibodies as determined by the effects of ionizing radiation. J Immunol (1967) 0.88
Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants. J Clin Invest (1991) 0.88
The complement sensitivity on PNH cells. Ser Haematol (1972) 0.88